Glucose Health, Inc. (OTCMKTS:GLUC) Shares Shorted: Short Interest Down 75.0% in October

Glucose Health, Inc. (OTCMKTS:GLUC) was the target of a large decrease in short interest in October. As of October 30th, there was short interest totaling 314 shares, a decrease of 75.0% from the October 15th total of 1,256 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average trading volume of 27,998 shares, the short-interest ratio is presently 0.0 days.

Glucose Health Stock Performance

Shares of OTCMKTS:GLUC opened at $0.44 on Thursday. The firm has a market cap of $12.53 million, a PE ratio of -14.67 and a beta of 1.30. The firm’s 50 day simple moving average is $0.37 and its 200-day simple moving average is $0.36. Glucose Health has a one year low of $0.12 and a one year high of $0.67.

Glucose Health (OTCMKTS:GLUC) last posted its quarterly earnings results on Friday, August 14th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $0.04 million for the quarter.

More Glucose Health News

Investors following GLUC have been watching these news items:

• Positive Sentiment: Reported short interest fell 75% to 314 shares as of October 30. That may modestly ease bearish positioning, though short interest was already extremely low—about 0.0% of shares—so the change is unlikely to be a meaningful driver by itself.
• Neutral Sentiment: Several outlets reported on a study suggesting a bedroom air purifier may help reduce blood-sugar spikes in people with prediabetes. This could add general attention to blood-sugar health, but the reports do not identify a direct benefit or business opportunity for GLUC. A Bedroom Air Purifier May Help Prevent Blood Sugar Spikes
• Neutral Sentiment: Other articles discuss diabetes prevention, glucose monitoring, diet, and blood-sugar risks. They provide broader category context but do not report developments involving Glucose Health.

Glucose Health Company Profile

Glucose Health, Inc. is a consumer health company focused on developing, marketing and selling nutritional supplements intended to support healthy blood glucose levels and overall metabolic health. The company’s product portfolio has included dietary supplement formulations marketed under the GlucoCil brand. These products are positioned as complementary wellness solutions for adults seeking nutritional support for blood sugar management and related health goals. Glucose Health primarily markets its products through direct-to-consumer and online channels.